Copyright
©The Author(s) 2016.
World J Hepatol. Feb 8, 2016; 8(4): 231-262
Published online Feb 8, 2016. doi: 10.4254/wjh.v8.i4.231
Published online Feb 8, 2016. doi: 10.4254/wjh.v8.i4.231
Ref. | Year published | Population | Bleeding from PHG | Transfusions required |
McCormack et al[3] | 1985 | 127 patients with portal hypertension of various etiologies | 29 patients out of 65 with PHG, representing 25% of the total number of bleeds from all sources; 9 episodes presenting with bleeding; 71 episodes of subsequent bleeding | 2-15 units required for 60 bleeds |
D'Amico et al[25] | 1990 | 212 patients with cirrhosis; 75 being treated with sclerotherapy | ||
Sarin et al[8] | 1992 | 107 patients with portal hypertension presenting with variceal bleeding, undergoing sclerotherapy | No bleeding before sclerotherapy from PHG (4/107 had PHG); 2/13 post-sclerotherapy patients who developed PHG | Average of 4 units per patient with range of 2-8 units |
Pérez-Ayuso et al[103] | 1991 | 54 cirrhotic patients with PHG, in a RCT to look for rebleeding; propranolol 26 vs control 28 | First hemorrhage: Acute/chronic bleeding in propranolol group 12/14; in control 12/16, rebleeding: Acute/chronic; in propranolol 6/6; in control 10/12 | |
Gostout et al[217] | 1993 | Patients admitted for GI bleeding (1496) | 12 patients (0.8%), representing 8% of nonvariceal bleeding in patients with liver disease | |
Primignani et al[34] | 2000 | 373 patients with cirrhosis; PHG in 299 patients (80.1%) | 8 PHG patients with acute bleeding; chronic bleeding in 34 patients | |
Merli et al[37] | 2004 | 222 cirrhotic patients with portal hypertension; 48 patients with PHG on enrollment | During follow up for 47 ± 28 (SD) mo, acute bleeding 9, chronic bleeding 7 from PHG | |
Kimura et al[218] | 2014 | 297 patients with living donor liver transplantation; retrospective analysis | 2 patients bled from PHG within 3 mo after transplantation |
- Citation: Gjeorgjievski M, Cappell MS. Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy. World J Hepatol 2016; 8(4): 231-262
- URL: https://www.wjgnet.com/1948-5182/full/v8/i4/231.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i4.231